All About Multiple Sclerosis

More MS news articles for January 2003

Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12502726&dopt=Abstract

Int Immunol 2003 Jan;15(1):59-69
Sewell D, Qing Z, Reinke E, Elliot D, Weinstock J, Sandor M, Fabry Z.
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI 53706, USA Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA.

Experimental autoimmune encephalomyelitis (EAE) is an animal model for multiple sclerosis (MS) characterized by chronic inflammatory demyelination of the central nervous system (CNS).

The pathology of EAE involves autoimmune CD4(+) T(h)1 cells.

There is a striking inverse correlation between the occurrence of parasitic and autoimmune diseases.

We demonstrate that in mice with Schistosoma mansoni ova immunization, the severity of EAE is reduced as measured by decreased clinical scores and CNS cellular infiltrates.

Disease suppression is associated with immune deviation in the periphery and the CNS, demonstrated by decreased IFN-gamma and increased IL-4, transforming growth factor-beta and IL-10 levels in the periphery, and increased frequency of IL-4 producing neuroantigen-specific T cells in the brain.

S. mansoni helminth ova treatment influenced the course of EAE in wild-type mice, but not in STAT6-deficient animals.

This indicates that STAT6 plays a critical role in regulating the ameliorating effect of S. mansoni ova treatment on the autoimmune response, and provides the direct link between helminth treatment, T(h)2 environment and improved EAE.

As some intestinal helminthic infections induce minimal pathology, they might offer a safe and inexpensive therapy to prevent and/or ameliorate MS.